| Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection F Ma, L Yang, Z Sun, J Chen, X Rui, Z Glass, Q Xu Science advances 6 (30), eabb4429, 2020 | 103 | 2020 |
| Intracellular delivery and biodistribution study of CRISPR/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles Y Li, J Bolinger, Y Yu, Z Glass, N Shi, L Yang, M Wang, Q Xu Biomaterials science 7 (2), 596-606, 2019 | 77 | 2019 |
| Efficient delivery of antisense oligonucleotides using bioreducible lipid nanoparticles in vitro and in vivo L Yang, F Ma, F Liu, J Chen, X Zhao, Q Xu Molecular Therapy-Nucleic Acids 19, 1357-1367, 2020 | 71 | 2020 |
| Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins Y Li, T Yang, Y Yu, N Shi, L Yang, Z Glass, J Bolinger, IJ Finkel, W Li, ... Biomaterials 178, 652-662, 2018 | 69 | 2018 |
| In situ cancer vaccination using lipidoid nanoparticles J Chen, M Qiu, Z Ye, T Nyalile, Y Li, Z Glass, X Zhao, L Yang, J Chen, ... Science advances 7 (19), eabf1244, 2021 | 61 | 2021 |
| Hyaluronic acid modification of RNase A and its intracellular delivery using lipid-like nanoparticles X Wang, Y Li, Q Li, CI Neufeld, D Pouli, S Sun, L Yang, P Deng, M Wang, ... Journal of Controlled Release 263, 39-45, 2017 | 58 | 2017 |
| mRNA Delivery Using Bioreducible Lipidoid Nanoparticles Facilitates Neural Differentiation of Human Mesenchymal Stem Cells X Zhao, Z Glass, J Chen, L Yang, DL Kaplan, Q Xu Advanced Healthcare Materials, 2000938, 2020 | 29 | 2020 |
| Enhanced protein degradation by intracellular delivery of pre-fused PROTACs using lipid-like nanoparticles J Chen, M Qiu, F Ma, L Yang, Z Glass, Q Xu Journal of controlled release 330, 1244-1249, 2021 | 21 | 2021 |
| In Vitro and In Vivo Study of Amphotericin B Formulation with Quaternized Bioreducible Lipidoids F Liu, L Yang, Y Li, A Junier, F Ma, J Chen, H Han, Z Glass, X Zhao, ... ACS Biomaterials Science & Engineering 6 (2), 1064-1073, 2020 | 19 | 2020 |
| A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases X Ma, P Zhou, A Kugelmass, D Toskic, M Warner, L Lee, T Fogaren, ... Gene Therapy 26 (5), 187-197, 2019 | 8 | 2019 |
| Biomater. Sci. S Li, F Tallia, AA Mohammed, MM Stevens, JR Jones | 7 | 2019 |
| Study the lipidoid nanoparticle mediated genome editing protein delivery using 3D intestinal tissue model QX Tao Yang, Haobo Han, Ying Chen, Liu Yang, Rachael Parker, Yamin Li, David ... Bioactive Materials 6, 3671–3677, 2021 | 3 | 2021 |
| Effective lipidoid nanoparticle delivery in vivo of siRNA targeting kappa light chain production in a murine xenograft model X Ma, P Zhou, A Kugelmass, D Toskic, M Warner, LX Lee, T Fogaren, ... Blood 132, 3208, 2018 | 2 | 2018 |
| Therapeutic Delivery of Nucleic Acid and Small Molecule Drug Cargos Using Bioreducible Lipid-Based Nanoparticles L Yang Tufts University, 2020 | | 2020 |
